Correction to Shire's Generic Adderall XR Approval Story On June 25
July 10 2012 - 04:08AM
Dow Jones News
"Shire Sinks On Generic Adderall XR Approval But Rebound Seen"
at 1250 GMT on June 25 incorrectly said Watson Pharmaceuticals had
already bought Actavis in the second paragraph.
Watson is still in the process of buying Actavis.
Watson (NYSE:WPI)
Historical Stock Chart
From Feb 2024 to Mar 2024
Watson (NYSE:WPI)
Historical Stock Chart
From Mar 2023 to Mar 2024